Abstract
There is significant public concern about the potential health effects of exposure to mercury vapour (Hg0) released from dental amalgam restorations. The purpose of this article is to provide information about the toxicokinetics of Hg0, evaluate the findings from the recent scientific and medical literature, and identify research gaps that when filled may definitively support or refute the hypothesis that dental amalgam causes adverse health effects.
Dental amalgam is a widely used restorative dental material that was introduced over 150 years ago. Most standard dental amalgam formulations contain approximately 50% elemental mercury. Experimental evidence consistently demonstrates that Hg0 is released from dental amalgam restorations and is absorbed by the human body. Numerous studies report positive correlations between the number of dental amalgam restorations or surfaces and urine mercury concentrations in non-occupationally exposed individuals. Although of public concern, it is currently unclear what adverse health effects are caused by the levels of Hg0 released from this restoration material. Historically, studies of occupationally exposed individuals have provided consistent information about the relationship between exposure to Hg0 and adverse effects reflecting both nervous system and renal dysfunction. Workers are usually exposed to substantially higher Hg0 levels than individuals with dental amalgam restorations and are typically exposed 8 hours per day for 20–30 years, whereas persons with dental amalgam restorations are exposed 24 hours per day over some portion of a lifetime. This review has uncovered no convincing evidence pointing to any adverse health effects that are attributable to dental amalgam restorations besides hypersensitivity in some individuals.
Similar content being viewed by others
References
US Department of Health and Human Services. Dental amalgam: a scientific review and recommended public health service strategy for research, education and regulation [online]. Available from URL: http://www.health.gov/environment/amalgam1/ct.htm [Accessed 2003 Jul 10]
US Department of Health and Human Services. Dental amalgam and alternative restorative materials [online]. Available from URL: http://www.health.gov/environment/amalgam2/contents.html [Accessed 2003 Jul 10]
The Commission of the European Union Ad Hoc Working Group on Amalgam. Ad Hoc Working Group Report on Amalgam [online]. Available from URL: http://www.nordiskadental.se/EUamalgam/amalgamrep.pdf [Accessed 2004 Feb 2]
Health Canada. Mercury and human health [online]. Available from URL: http://www.hc-sc-gc.ca/english/pdf/iyh/mercury_e.pdf [Accessed 2004 Feb 2]
Conseil d’Evaluation des Technologies de la Sante du Quebec (CETS). Reports from the Conseil d’Evaluation des Technologies de la Sante du Quebec (CETS). The safety of dental amalgam: a state-of-the-art review. Int J Technol Assess Health Care 1997; 13(4): 639–42
National Health and Medical Research Council. Dental amalgam and mercury in denistry [online]. Available from URL: http://www.health.gov.au/nhmrc/publications/pdf/dl7.pdf [Accessed 2004 Feb 2]
WHO consensus statement on dental amalgam. FDI World Dental Federation. FDI World 1997; 6(6): 9
German Ministry of Health, German Institute for Drugs and Medical Devices (BrArM), Federal Dental Chamber, Kassenzahnärztliche Bundesvereinigung, German Scientific Dental Association, German Association for Operative Dentistry, et al. Consensus statement on restorative materials in dentistry. Bonn: German Ministry of Health, 1997 Jan 7
Berlin M. Mercury in dental-filling materials: an updated risk analysis in environmental medical terms [online]. Available from URL: http://www.dentalmaterial.gov.se/mercury.pdf [Accessed 2003 Jul 10]
American Conference of Governmental Industrial Hygienists. Threshold limit values and biological exposure indices. Cincinnati (OH): Signature Publications, 2004
American Conference of Governmental Industrial Hygienists. Mercury, all forms except alkyl. In: TLV® chemical substances. 7th ed. Cincinnati (OH): American Conference of Governmental Industrial Hygienists, 2001
Satoh H. Occupational and environmental toxicology of mercury and its compounds. Ind Health 2000; 38(2): 153–64
Schnellmann RG. Toxic responses of the kidney. In: Klaassen CD, editor. Casarett and Doull’s toxicology. 6th ed. New York: McGraw-Hill, 2001: 491–514
Zalups RK. Molecular interactions with mercury in the kidney. Pharmacol Rev 2000; 52(1): 113–43
Boogaard PJ, Houtsma AT, Journee HL, et al. Effects of exposure to elemental mercury on the nervous system and the kidneys of workers producing natural gas. Arch Environ Health 1996; 51(2): 108–15
Ellingsen DG, Efskind J, Berg KJ, et al. Renal and immunologic markers for chloralkali workers with low exposure to mercury vapor. Scand J Work Environ Health 2000; 26(5): 427–35
Mandic L, Radmila M, Jelena A, et al. Change in the iso-enzyme profiles of urinary N-acetyl-beta-D-glucosoaminidase in workers exposed to mercury. Toxicol Ind Health 2002; 18(5): 207–14
Agency for Toxic Substances and Disease Registry. Toxicological profile for mercury [online]. Available from URL: http://www.atsdr.cdc.gov/toxprofiles/tp46.html [Accessed 2003 Jul 10]
US General Accounting Office. Reproductive and developmental toxicants: regulatory actions provide uncertain protection. GAO/PEMD-92-3. Washington, DC: US General Accounting Office, 1991
Mackert Jr JR, Berglund A. Mercury exposure from dental amalgam fillings: absorbed dose and the potential for adverse health effects. Crit Rev Oral Biol Med 1997; 8(4): 410–36
Eley BM. The future of dental amalgam: a review of the literature. Part 3: mercury exposure from amalgam restorations in dental patients. Br Dent J 1997; 182(9): 333–8
Lyons K. Direct placement restorative materials for use in posterior teeth: the current options. N Z Dent J 2003; 99(1): 10–5
Eley BM. The future of dental amalgam: a review of the literature. Part 2: mercury exposure in dental practice. Br Dent J 1997; 182(8): 293–7
Brown LJ, Kaste LM, Sciwitz RH, et al. Dental caries and sealant usage in US children, 1988–1991: selected findings from the Third National Health and Nutrition Examination Survey. J Am Dent Assoc 1996; 127(3): 335–43
Eklund SA, Pittman JL, Smith RC. Trends in dental care among insured Americans: 1980 to 1995. J Am Dent Assoc 1997; 128(2): 171–8
US Food and Drug Administration. Consumer update: dental amalgams [online]. Available from URL: http://www.fda.gov/cdrh/consumer/amalgams.html [Accessed 2003 Jul 10]
US Environmental Protection Agency Office of Air Quality Standards. Mercury report to Congress [online]. Available from URL: http://www.epa.gov/oar/mercover.html [Accessed 2003 Aug 25]
US Food and Drug Administration. Prohibited ingredients and related safety issues [online]. Available from URL: http://vm.cfsan.fda.gov/~dms/cos-210.html [Accessed 2004 Jun 30]
National Research Council. Toxicological effects of methylmercury. Washington, DC: National Academy Press, 2000
Clarkson TW. The three modern faces of mercury. Environ Health Perspect 2002; 110Suppl. 1: 11–23
Hursh JB, Cherian MG, Clarkson TW, et al. Clearance of mercury (Hg-197, Hg-203) vapor inhaled by human subjects. Arch Environ Health 1976; 31(6): 302–9
Sandborgh-Englund G, Elinder CG, Johanson G, et al. The absorption, blood levels, and excretion of mercury after a single dose of mercury vapor in humans. Toxicol Appl Pharmacol 1998; 150(1): 146–53
Magos L, Halbach S, Clarkson TW. Role of catalase in the oxidation of mercury vapor. Biochem Pharmacol 1978; 27(9): 1373–7
Rahola T, Hattula T, Korolainen A, et al. Elimination of free and protein-bound ionic mercury (203Hg2+) in man. Ann Clin Res 1973; 5(4): 214–9
Goyer RA, Clarkson TW. Toxic effects of metals. In: Klaassen CD, editor. Casarett & Doull’s toxicology. 6th ed. New York: McGraw-Hill, 2001: 811–67
Engqvist A, Colmsjo A, Skare I. Speciation of mercury excreted in feces from individuals with amalgam fillings. Arch Environ Health 1998; 53(3): 205–13
af Geijersstam E, Sandborgh-Englund G, Jonsson F, et al. Mercury uptake and kinetics after ingestion of dental amalgam. J Dent Res 2001; 80(9): 1793–6
Hursh JB, Clarkson TW, Miles EF, et al. Percutaneous absorption of mercury vapor by man. Arch Environ Health 1989; 44(2): 120–7
Cherian MG, Hursh JB, Clarkson TW, et al. Radioactive mercury distribution in biological fluids and excretion in human subjects after inhalation of mercury vapor. Arch Environ Health 1978; 33(3): 109–14
Barregard L, Quelquejeu G, Sallsten G, et al. Dose-dependent elimination kinetics for mercury in urine: observations in subjects with brief but high-level exposure. Int Arch Occup Environ Health 1996; 68(5): 345–8
Jonsson F, Sandborgh-Englund G, Johanson G. A compartmental model for the kinetics of mercury vapor in humans. Toxicol Appl Pharmacol 1999; 155(2): 161–8
Roels H, Abdeladim S, Ceulemans E, et al. Relationships between the concentrations of mercury in air and in blood or urine in workers exposed to mercury vapour. Ann Occup Hyg 1987; 31(2): 135–45
Hursh JB, Clarkson TW, Nowak TV, et al. Prediction of kidney mercury content by isotope techniques. Kidney Int 1985; 27(6): 898–907
Takahashi Y, Tsuruta S, Hasegawa J, et al. Release of mercury from dental amalgam fillings in pregnant rats and distribution of mercury in maternal and fetal tissues. Toxicology 2001; 163(2–3): 115–26
Takahashi Y, Tsuruta S, Arimoto M, et al. Placental transfer of mercury in pregnant rats which received dental amalgam restorations. Toxicology 2003; 185(1–2): 23–33
Warfvinge K, Hua J, Logdberg B. Mercury distribution in cortical areas and fiber systems of the neonatal and maternal adult cerebrum after exposure of pregnant squirrel monkeys to mercury vapor. Environ Res 1994; 67(2): 196–208
Warfvinge K, Hua J, Berlin M. Mercury distribution in the rat brain after mercury vapor exposure. Toxicol Appl Pharmacol 1992; 117(1): 46–52
Oskarsson A, Schultz A, Skerfving S, et al. Total and inorganic mercury in breast milk in relation to fish consumption and amalgam in lactating women. Arch Environ Health 1996; 51(3): 234–41
World Health Organization, International Programme on Chemical Safety. Inorganic mercury: environmental health criteria 118. Geneva: World Health Organization, 1991
Kostial K, Kello D, Jugo S, et al. Influence of age on metal metabolism and toxicity. Environ Health Perspect 1978; 25: 81–6
Nordberg M, Nordberg GF. Toxicological aspects of metallothionein. Cell Mol Biol (Noisy-le-Grand) 2000; 46(2): 451–63
Zalups RK, Koropatnick J. Temporal changes in metallothionein gene transcription in rat kidney and liver: relationship to content of mercury and metallothionein protein. J Pharmacol Exp Ther 2000; 295(1): 74–82
Clarkson TW, Friberg LT, Hursh JB, et al. The prediction of intake of mercury vapor from amalgams. In: Clarkson TW, Friberg LT, Nordberg GF, et al., editors. Biological monitoring of toxic metals. New York: Plenum Press, 1988: 247–64
Richardson GM, Allan M. A Monte Carlo assessment of mercury exposure and risks from dental amalgam. Hum Ecol Risk Assess 1996; 2(4): 709–61
Kingman A, Albertini T, Brown LJ. Mercury concentrations in urine and whole blood associated with amalgam exposure in a US military population. J Dent Res 1998; 77(3): 461–71
Barregard L. Biological monitoring of exposure to mercury vapor. Scand J Work Environ Health 1993; 19Suppl. 1: 45–9
Barregard L, Horvat M, Schutz A. No indication of in vivo methylation of inorganic mercury in chloralkali workers. Environ Res 1994; 67(2): 160–7
Kerper LE, Ballatori N, Clarkson TW. Methylmercury transport across the blood-brain barrier by an amino acid carrier. Am J Physiol 1992; 262 (5 Pt 2): R761–5
Weiss B, Clarkson TW, Simon W. Silent latency periods in methylmercury poisoning and in neurodegenerative disease. Environ Health Perspect 2002; 110Suppl. 5: 851–4
Castoldi AF, Coccini T, Ceccatelli S, et al. Neurotoxicity and molecular effects of methylmercury. Brain Res Bull 2001; 55(2): 197–203
Burbacher TM, Rodier PM, Weiss B. Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals. Neurotoxicol Teratol 1990; 12(3): 191–202
Clarkson TW, Nordberg GF, Sager PR. Reproductive and developmental toxicity of metals. Scand J Work Environ Health 1985; 11 (3 spec. no.): 145–54
Marsh DO, Myers GJ, Clarkson TW, et al. Fetal methylmercury poisoning: clinical and toxicological data on 29 cases. Ann Neurol 1980; 7(4): 348–53
Magos L, Brown AW, Sparrow S, et al. The comparative toxicology of ethyl- and methylmercury. Arch Toxicol 1985; 57(4): 260–7
Norseth T, Clarkson TW. Studies on the biotransformation of 203Hg-labeled methyl mercury chloride in rats. Arch Environ Health 1970; 21(6): 717–27
Syversen TL. Distribution of mercury in enzymatically characterized subcellular fractions from the developing rat brain after injections of methylmercuric chloride and diethylmercury. Biochem Pharmacol 1974; 23(21): 2999–3007
Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295–300
Becker K, Schulz C, Kaus S, et al. German Environmental Survey 1998 (GerES III): environmental pollutants in the urine of the German population. Int J Hyg Environ Health 2003; 206(1): 15–24
Gabrio T, Benedikt G, Broser S, et al. 10 years of observation by public health offices in Baden-Wurttemberg: assessment of human biomonitoring for mercury due to dental amalgam fillings and other sources. Gesundheitswesen 2003; 65(5): 327–35
Apostoli P, Cortesi I, Mangili A, et al. Assessment of reference values for mercury in urine: the results of an Italian polycentric study. Sci Total Environ 2002; 289(1–3): 13–24
US Department of Health and Human Services. Second national report on human exposure to environmental chemicals (NCEH pub. no. 01-0716) [online]. Available from URL: http://www.cdc.gov/exposurereport/pdf/SecondNER.pdf [Accessed 2003 Dec 19]
Ozuah PO, Lesser MS, Woods JS, et al. Mercury exposure in an urban pediatric population. Ambul Pediatr 2003; 3(1): 24–6
Sallsten G, Thoren J, Barregard L, et al. Long-term use of nicotine chewing gum and mercury exposure from dental amalgam fillings. J Dent Res 1996; 75(1): 594–8
Isacsson G, Barregard L, Sciden A, et al. Impact of nocturnal bruxism on mercury uptake from dental amalgams. Eur J Oral Sci 1997; 105(3): 251–7
Khordi-Mood M, Sarraf-Shirazi AR, Balali-Mood M. Urinary mercury excretion following amalgam filling in children. J Toxicol Clin Toxicol 2001; 39(7): 701–5
Sandborgh-Englund G, Elinder CG, Langworth S, et al. Mercury in biological fluids after amalgam removal. J Dent Res 1998; 77(4): 615–24
Halbach S, Kremers L, Willruth H, et al. Systemic transfer of mercury from amalgam fillings before and after cessation of emission. Environ Res 1998; 77(2): 115–23
Kremers L, Halbach S, Willruth H, et al. Effect of rubber dam on mercury exposure during amalgam removal. Eur J Oral Sci 1999; 107(3): 202–7
Berglund A, Molin M. Mercury levels in plasma and urine after removal of all amalgam restorations: the effect of using rubber dams. Dent Mater 1997; 13(5): 297–304
Ellingsen DG, Efskind J, Haug E, et al. Effects of low mercury vapour exposure on the thyroid function in chloralkali workers. J Appl Toxicol 2000; 20(6): 483–9
Soleo L, Vacca A, Vimercati L, et al. Minimal immunological effects on workers with prolonged low exposure to inorganic mercury. Occup Environ Med 1997; 54(6): 437–42
Ibbotson SH, Speight EL, Macleod RI, et al. The relevance and effect of amalgam replacement in subjects with oral lichenoid reactions. Br J Dermatol 1996; 134(3): 420–3
Koch P, Bahmer FA. Oral lesions and symptoms related to metals used in dental restorations: a clinical, allergological, and histologie study. J Am Acad Dermatol 1999; 41 (3 Pt 1): 422–30
Thornhill MH, Pemberton MN, Simmons RK, et al. Amalgam-contact hypersensitivity lesions and oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95(3): 291–9
Magnin P, Stuck M, Meier E, et al. Amalgam-associated lichenoid lesions of the oral mucosa: filling replacement therapy. Schweiz Monatsschr Zahnmed 2003; 113(2): 143–50
Casetta I, Invernizzi M, Granieri E. Multiple sclerosis and dental amalgam: case-control study in Ferrara, Italy. Neuroepidemiology 2001; 20(2): 134–7
McGrother CW, Dugmore C, Phillips MJ, et al. Multiple sclerosis, dental caries and fillings: a case-control study. Br Dent J 1999; 187(5): 261–4
Factor-Litvak P, Hasselgren G, Jacobs D, et al. Mercury derived from dental amalgams and neuropsychologic function. Environ Health Perspect 2003; 111(5): 719–23
Nitschke I, Muller F, Smith J, et al. Amalgam fillings and cognitive abilities in a representative sample of the elderly population. Gerodontology 2000; 17(1): 39–44
Bjorkman L, Pedersen NL, Lichtenstein P. Physical and mental health related to dental amalgam fillings in Swedish twins. Community Dent Oral Epidemiol 1996; 24(4): 260–7
Echeverria D, Aposhian HV, Woods JS, et al. Neurobehavioral effects from exposure to dental amalgam Hg (o): new distinctions between recent exposure and Hg body burden. FASEB J 1998; 12(11): 971–80
Pendergrass JC, Haley BE, Vimy MJ, et al. Mercury vapor inhalation inhibits binding of GTP to tubulin in rat brain: similarity to a molecular lesion in Alzheimer diseased brain. Neurotoxicology 1997; 18(2): 315–24
Leong CC, Syed NI, Lorscheider FL. Retrograde degeneration of neurite membrane structural integrity of nerve growth cones following in vitro exposure to mercury. Neuroreport 2001; 12(4): 733–7
Fung YK, Meade AG, Rack EP, et al. Mercury determination in nursing home patients with Alzheimer’s disease. Gen Dent 1996; 44(1): 74–8
Letz R, Gerr F, Cragle D, et al. Residual neurologic deficits 30 years after occupational exposure to elemental mercury. Neurotoxicology 2000; 21(4): 459–74
Gun RT, Korten AE, Jorm AF, et al. Occupational risk factors for Alzheimer disease: a case-control study. Alzheimer Dis Assoc Disord 1997; 11(1): 21–7
Cornett CR, Ehmann WD, Wekstein DR, et al. Trace elements in Alzheimer’s disease pituitary glands. Biol Trace Elem Res 1998; 62(1–2): 107–14
Cornett CR, Markesbery WR, Ehmann WD. Imbalances of trace elements related to oxidative damage in Alzheimer’s disease brain. Neurotoxicology 1998; 19(3): 339–45
Fung YK, Meade AG, Rack EP, et al. Brain mercury in neurodegenerative disorders. J Toxicol Clin Toxicol 1997; 35(1): 49–54
Saxe SR, Wekstein MW, Kryscio RJ, et al. Alzheimer’s disease, dental amalgam and mercury. J Am Dent Assoc 1999; 130(2): 191–9
Gorell JM, Johnson CC, Rybicki BA, et al. Occupational exposures to metals as risk factors for Parkinson’s disease. Neurology 1997; 48(3): 650–8
Gorell JM, Rybicki BA, Cole JC, et al. Occupational metal exposures and the risk of Parkinson’s disease. Neuroepidemiology 1999; 18(6): 303–8
Seidler A, Hellenbrand W, Robra BP, et al. Possible environmental, occupational, and other etiologic factors for Parkinson’s disease: a case-control study in Germany. Neurology 1996; 46(5): 1275–84
Hanf V, Forstmann A, Costea JE, et al. Mercury in urine and ejaculate in husbands of barren couples. Toxicol Lett 1996; 88(1–3): 227–31
Yang JM, Chen QY, Jiang XZ. Effects of metallic mercury on the perimenstrual symptoms and menstrual outcomes of exposed workers. Am J Ind Med 2002; 42(5): 403–9
Ask K, Akesson A, Berglund M, et al. Inorganic mercury and methylmercury in placentas of Swedish women. Environ Health Perspect 2002; 110(5): 523–6
Vahter M, Akesson A, Lind B, et al. Longitudinal study of methylmercury and inorganic mercury in blood and urine of pregnant and lactating women, as well as in umbilical cord blood. Environ Res 2000; 84(2): 186–94
Fredriksson A, Dencker L, Archer T, et al. Prenatal coexposure to metallic mercury vapour and methylmercury produce interactive behavioural changes in adult rats. Neurotoxicol Teratol 1996; 18(2): 129–34
Newland MC, Warfvinge K, Berlin M. Behavioral consequences of in utero exposure to mercury vapor: alterations in lever-press durations and learning in squirrel monkeys. Toxicol Appl Pharmacol 1996; 139(2): 374–86
Berglund A, Molin M. Mercury vapor release from dental amalgam in patients with symptoms allegedly caused by amalgam fillings. Eur J Oral Sci 1996; 104(1): 56–63
Zimmer H, Ludwig H, Bader M, et al. Determination of mercury in blood, urine and saliva for the biological monitoring of an exposure from amalgam fillings in a group with self-reported adverse health effects. Int J Hyg Environ Health 2002; 205(3): 205–11
Marcusson JA. Psychological and somatic subjective symptoms as a result of dermatological patch testing with metallic mercury and phenyl mercuric acetate. Toxicol Lett 1996; 84(2): 113–22
Stromberg R, Langworth S, Soderman E. Mercury inductions in persons with subjective symptoms alleged to dental amalgam fillings. Eur J Oral Sci 1999; 107(3): 208–14
Aposhian HV, Morgan DL, Queen HL, et al. Vitamin C, glutathione, or lipoic acid did not decrease brain or kidney mercury in rats exposed to mercury vapor. J Toxicol Clin Toxicol 2003; 41(4): 339–47
Acknowledgements
This review summarises the findings of a recent Life Sciences Research Office (LSRO) report (Brownawell AM, editor. Review and analysis of the potential adverse health effects of dental amalgam. Bethesda (MD): Life Sciences Research Office, 2004). The original project was funded in whole or in part with federal funds from the National Institute of Dental and Craniofacial Research, National Institutes of Health, under contract no. N01-DE-12635. The publication of this review has been funded solely by LSRO. The authors declare that they have no competing financial interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brownawell, A.M., Berent, S., Brent, R.L. et al. The Potential Adverse Health Effects of Dental Amalgam. Toxicol Rev 24, 1–10 (2005). https://doi.org/10.2165/00139709-200524010-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00139709-200524010-00001